Coinspeaker Nestle to Acquire Aimmune, Food Allergy Drug Maker, for $2.6 BillionNestle S.A. has secured a $2.6 billion acquisition deal with Aimmune (AIMT). Starting with Aimmune's Palforzia, Nestle hope to expand its food allergy portfolio.Nestle to Acquire Aimmune, Food Allergy Drug Maker, for $2.6 Billion